Poseida Therapeutics Provides Update on Phase 1 Trial of P-BCMA-101 at the 2020 American Society of Hematology Annual Meeting ...Middle East

SAN DIEGO, Dec. 5, 2020 /PRNewswire/ -- Poseida Therapeutics, Inc. (NASDAQ:PSTX), a clinical-stage biopharmaceutical company utilizing proprietary gene engineering platform technologies to create cell and gene therapeutics with the capacity to cure, today reported results of an ongoing...

Hence then, the article about poseida therapeutics provides update on phase 1 trial of p bcma 101 at the 2020 american society of hematology annual meeting was published today ( Saturday 05/12/2020 - 10:00 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Poseida Therapeutics Provides Update on Phase 1 Trial of P-BCMA-101 at the 2020 American Society of Hematology Annual Meeting )

Also on site :

• Celine Dion to Make Concert Comeback in Paris
• Hacks' Deborah Vance Fights To Reclaim The Spotlight In Final Season Trailer — Plus, Get Premiere Date
• How Chuck Norris Created the Manosphere